EUVIMED · CrossrefZeitschrift
Digestive and Liver Disease Supplements
ISSN 1594-5804 · Elsevier BV
Neueste Artikel
Editorial Board
Foreword
The role of bacterial flora and its products in the functioning of the small intestine
Butyric acid: pharmacological aspects and routes of administration
Butyrate in the treatment of experimental models of colitis
Efficacy of butyrate in the treatment of diarrhoea-predominant irritable bowel syndrome
Efficacy of butyrate on rectal toxicity of radiotherapy in prostate cancer patients
Butyrate in the treatment of ulcerative colitis
Efficacy of butyrate in the treatment of mild to moderate Crohn's disease
Editorial Board
Crohn's Disease: Achieving Patients' Benefits Paris, 27th October 2007
Crohn's disease classification and its clinical usefulness
Updates on diagnosis: new tools? How can we measure activity?
Therapeutic goals in IBD
The relevance of mucosal healing
Conventional drugs: the unmet needs
How do biological drugs meet treatment goals in anti-TNF naive patients, in patients with anti-TNF failure and in fistulizing patients?
Top down therapy in Crohn's disease
Improving patients' QoL: how the success of treatment can improve workability
Safety of biologics – which lessons learned?
Safety of biologics: which lessons learned? The rheumatologist's point of view
Opportunistic infections and anti-tumor necrosis factor antagonists in patients with IBD: prevention and diagnosis
New developments in biologics therapy: what about from the medical point of view?
Editorial Board
Introduction: Bacteria, gas and functional gastrointestinal disorders
Introduction
Liver Transplantation Interdisciplinary Conference (1)
Editorial Board
Introduction
Chronic hepatitis B in 2008
EUVIMED